Xiaohong Zhao

5PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyInnate immunityPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 06, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Birui Pan, Qinli Sun, Ruifeng Li

|Feb 05, 2025
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39.

Sang-Nee Tan, Jing Hao, Jing Ge

|Dec 04, 2023
A novel memory-like Tfh cell subset is precursor to effector Tfh cells in recall immune responses.

Han Feng, Zixuan Zhao, Xiaohong Zhao

|Jan 23, 2023
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection.

Qinli Sun, Xiaohong Zhao, Ruifeng Li

|Jan 18, 2023
Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s.

Yuling Li, Jing Ge, Xiaohong Zhao

Pageof 1